Alak Manna

775 total citations
37 papers, 532 citations indexed

About

Alak Manna is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Alak Manna has authored 37 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Genetics and 9 papers in Oncology. Recurrent topics in Alak Manna's work include Chronic Lymphocytic Leukemia Research (8 papers), Calcium signaling and nucleotide metabolism (7 papers) and Immune Cell Function and Interaction (4 papers). Alak Manna is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Calcium signaling and nucleotide metabolism (7 papers) and Immune Cell Function and Interaction (4 papers). Alak Manna collaborates with scholars based in United States, India and Argentina. Alak Manna's co-authors include Mitali Chatterjee, Asher Chanan‐Khan, Aneel Paulus, Subrata Chattopadhyay, Ajay K. Bauri, Soumita De, Padma Das, Avijit Sarkar, Sikander Ailawadhi and Deepak Kumar and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Nature Immunology.

In The Last Decade

Alak Manna

34 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alak Manna United States 14 173 132 110 99 75 37 532
Roberta R. Ruela-de-Sousa Brazil 11 382 2.2× 47 0.4× 99 0.9× 29 0.3× 30 0.4× 12 556
Viviana Roman Romania 11 205 1.2× 66 0.5× 72 0.7× 59 0.6× 20 0.3× 21 417
Long Liang China 19 431 2.5× 92 0.7× 156 1.4× 25 0.3× 99 1.3× 60 871
Huijie Guo China 17 456 2.6× 103 0.8× 181 1.6× 77 0.8× 130 1.7× 38 872
Youzhong Wan China 13 354 2.0× 75 0.6× 76 0.7× 60 0.6× 25 0.3× 35 616
Shota Moriya Japan 17 415 2.4× 67 0.5× 129 1.2× 31 0.3× 292 3.9× 30 718
Sima Mansoori Derakhshan Iran 5 325 1.9× 64 0.5× 69 0.6× 27 0.3× 58 0.8× 22 533
Namrata Rastogi India 14 379 2.2× 97 0.7× 148 1.3× 18 0.2× 64 0.9× 20 706
Jyoti Kanwar India 5 517 3.0× 75 0.6× 249 2.3× 31 0.3× 71 0.9× 25 867
Adrian Bogdan Țigu Romania 14 463 2.7× 79 0.6× 147 1.3× 35 0.4× 65 0.9× 68 912

Countries citing papers authored by Alak Manna

Since Specialization
Citations

This map shows the geographic impact of Alak Manna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alak Manna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alak Manna more than expected).

Fields of papers citing papers by Alak Manna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alak Manna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alak Manna. The network helps show where Alak Manna may publish in the future.

Co-authorship network of co-authors of Alak Manna

This figure shows the co-authorship network connecting the top 25 collaborators of Alak Manna. A scholar is included among the top collaborators of Alak Manna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alak Manna. Alak Manna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hamaidi, Imène, Alak Manna, İsmail Can, et al.. (2026). SIRT2-mediated deacetylation of LCK governs the magnitude of T cell receptor signaling. Nature Immunology. 27(2). 213–224.
2.
Manna, Alak, et al.. (2025). Colistin resistance in the era of antimicrobial resistance: challenges and strategic countermeasures. Folia Microbiologica. 70(5). 915–930.
3.
4.
Luo, Yan, Yaqing Qie, Martha E. Gadd, et al.. (2023). Translational development of BAFF-R-specific chimeric antigen receptor T-cell therapy targeting B-cell lymphoid malignancies.. Journal of Clinical Oncology. 41(16_suppl). e19501–e19501. 1 indexed citations
5.
Badar, Talha, Alak Manna, Martha E. Gadd, Mohamed A. Kharfan‐Dabaja, & Hong Qin. (2022). Prospect of CAR T-cell therapy in acute myeloid leukemia. Expert Opinion on Investigational Drugs. 31(2). 211–220. 9 indexed citations
6.
Madamsetty, Vijay Sagar, Aneel Paulus, Sharoon Akhtar, et al.. (2020). Novel tumor-targeted liposomes comprised of an MDM2 antagonist plus proteasome inhibitor display anti-tumor activity in a xenograft model of bortezomib-resistant Waldenstrom macroglobulinemia. Leukemia & lymphoma. 61(10). 2399–2408. 4 indexed citations
7.
Manna, Alak, Salman Ahmed, Sharoon Akhtar, et al.. (2019). Targeting CD38 Enhances the Antileukemic Activity of Ibrutinib in Chronic Lymphocytic Leukemia. Clinical Cancer Research. 25(13). 3974–3985. 31 indexed citations
8.
Rosenfeld, Steven S., Alfredo Quiñones‐Hinojosa, Aneel Paulus, et al.. (2019). Survival trends in glioblastoma and association with treating facility volume. Journal of Clinical Neuroscience. 68. 271–274. 16 indexed citations
9.
Laali, Kenneth K., Frederick J. Troendle, Gabriela L. Borosky, et al.. (2018). Synthesis, Computational Docking Study, and Biological Evaluation of a Library of Heterocyclic Curcuminoids with Remarkable Antitumor Activity. ChemMedChem. 13(18). 1895–1908. 14 indexed citations
10.
Schiapparelli, Paula, Alak Manna, Aneel Paulus, et al.. (2018). CD38 Targeted Therapy in Glioblastoma: A Step Forward. (P4.160). Neurology. 90(15_supplement). 1 indexed citations
11.
Manna, Alak, Laura J. Lewis‐Tuffin, Sikander Ailawadhi, Asher Chanan‐Khan, & Aneel Paulus. (2018). Using anti-CD38 immunotherapy to enhance anti-tumor T-cell immunity in chronic lymphocytic leukemia (CLL). The Journal of Immunology. 200(Supplement_1). 58.17–58.17. 2 indexed citations
12.
13.
14.
De, Soumita, Alak Manna, Sunanda Kundu, et al.. (2016). Allylpyrocatechol Attenuates Collagen-Induced Arthritis via Attenuation of Oxidative Stress Secondary to Modulation of the MAPK, JAK/STAT, and Nrf2/HO-1 Pathways. Journal of Pharmacology and Experimental Therapeutics. 360(2). 249–259. 29 indexed citations
15.
Manna, Alak, et al.. (2016). Impact of MAPK and PI3K/AKT signaling pathways on Malabaricone-A induced cytotoxicity in U937, a histiocytic lymphoma cell line. International Immunopharmacology. 39. 34–40. 11 indexed citations
16.
Chatterjee, Mitali, et al.. (2016). A study of the free radical scavenging effects of Piper betle leaf extract in patients with vitiligo. Indian Journal of Dermatology Venereology and Leprology. 83(1). 40–40. 3 indexed citations
17.
Kumar, Deepak, Rupashree Sen, Alak Manna, et al.. (2015). Andrographolide Analogue Induces Apoptosis and Autophagy Mediated Cell Death in U937 Cells by Inhibition of PI3K/Akt/mTOR Pathway. PLoS ONE. 10(10). e0139657–e0139657. 60 indexed citations
18.
Manna, Alak, Ajay K. Bauri, Subrata Chattopadhyay, & Mitali Chatterjee. (2015). Generation of Redox Imbalance Mediates the Cytotoxic Effect of Malabaricone-A in a Multidrug Resistant Cell Line. Anti-Cancer Agents in Medicinal Chemistry. 15(9). 1156–1163. 7 indexed citations
19.
Mukhopadhyay, Debanjan, Nilay Kanti Das, Alak Manna, et al.. (2012). Evaluation of serological markers to monitor the disease status of Indian post kala-azar dermal leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene. 106(11). 668–676. 26 indexed citations
20.
Chatterjee, Shilpak, Satyajit Das, Paramita Chakraborty, et al.. (2012). Myeloid derived suppressor cells (MDSCs) can induce the generation of Th17 response from naïve CD4+ T cells. Immunobiology. 218(5). 718–724. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberta R. Ruela-de-Sousa Breakdown of academic impact, for papers by Viviana Roman Breakdown of academic impact, for papers by Long Liang Breakdown of academic impact, for papers by Huijie Guo Breakdown of academic impact, for papers by Youzhong Wan Breakdown of academic impact, for papers by Shota Moriya Breakdown of academic impact, for papers by Sima Mansoori Derakhshan Breakdown of academic impact, for papers by Namrata Rastogi Breakdown of academic impact, for papers by Jyoti Kanwar Breakdown of academic impact, for papers by Adrian Bogdan Țigu
Rankless by CCL
2026